OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor

There is an urgent need for new, potent antituberculosis (anti-TB) drugs with novel mechanisms of action that can be included in new regimens to shorten the treatment period for TB. After screening a library of carbostyrils, we optimized 3,4-dihydrocarbostyril derivatives and identified OPC-167832 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariguchi, Norimitsu, Chen, Xiuhao, Hayashi, Yohei, Kawano, Yoshikazu, Fujiwara, Mamoru, Matsuba, Miki, Shimizu, Hiroshi, Ohba, Yoshio, Nakamura, Izuru, Kitamoto, Ryuki, Shinohara, Toshio, Uematsu, Yukitaka, Ishikawa, Shunpei, Itotani, Motohiro, Haraguchi, Yoshikazu, Takemura, Isao, Matsumoto, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269503/
https://www.ncbi.nlm.nih.gov/pubmed/32229496
http://dx.doi.org/10.1128/AAC.02020-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269503/
https://www.ncbi.nlm.nih.gov/pubmed/32229496
http://dx.doi.org/10.1128/AAC.02020-19

Ejemplares similares